Cover Image

AD-CDO: A Lightweight Ontology for Representing Eligibility Criteria in Alzheimer's Disease Clinical Trials

Fuente: arXiv

Saved in:

Bibliographic Details
Main Authors:	Sun, Zenan, Abeysinghe, Rashmie, Li, Xiaojin, Hu, Xinyue, Cui, Licong, Zhang, Guo-Qiang, Bian, Jiang, Tao, Cui
Format:	Preprint
Published:	2025
Subjects:	Computation and Language
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Alzheimer's Disease Common Data Element Ontology for Clinical Trials (AD-CDO)
by: Sun, Zenan
Published: (2026)

$\texttt{AMEND++}$: Benchmarking Eligibility Criteria Amendments in Clinical Trials
by: Das, Trisha, et al.
Published: (2026)

Evolution of Eligibility Criteria in Inflammatory Bowel Disease Clinical Trials: A Clinical Trial Databank Analysis
by: An Outtier, et al.
Published: (2024)

Editorial: Striking the Right Balance for Eligibility Criteria for Clinical Trials in Inflammatory Bowel Disease
by: Virginia Solitano, et al.
Published: (2025)

TrialCompass: Visual Analytics for Enhancing the Eligibility Criteria Design of Clinical Trials
by: Sheng, Rui, et al.
Published: (2025)

Self-explainable Graph Neural Network for Alzheimer's Disease And Related Dementias Risk Prediction
by: Hu, Xinyue, et al.
Published: (2023)

Exploring the Generalization of Cancer Clinical Trial Eligibility Classifiers Across Diseases
by: Yang, Yumeng, et al.
Published: (2024)

Adjusting for Selection Bias Due to Missing Eligibility Criteria in Emulated Target Trials
by: Benz, Luke, et al.
Published: (2024)

The Clinical Trials Landscape for Alzheimer's Disease
by: Guoping Shen, et al.
Published: (2025)

Systematic Literature Review on Clinical Trial Eligibility Matching
by: Sharif, Muhammad Talha, et al.
Published: (2025)

Associations Between Alzheimer’s Disease and Obesity: Clinical Trials of NA‐831 for AD and NA‐931 for Obesity
by: Lloyd Tran, et al.
Published: (2024)

Advancing Biomedicine with Graph Representation Learning: Recent Progress, Challenges, and Future Directions
by: Li, Fang, et al.
Published: (2023)

A Comparative Study of Recent Large Language Models on Generating Hospital Discharge Summaries for Lung Cancer Patients
by: Li, Yiming, et al.
Published: (2024)

Most Patients Attending a Geriatrician‐Led Memory Clinic are Not Eligible for Alzheimer's Disease‐Modifying Drugs
by: Brendan Flanagan, et al.
Published: (2025)

EXPLORING THE DIVERGENCE OF FUNCTIONAL AND EVOLUTIONAL INTERACTIONS BETWEEN FUNGI AND BACTERIA
by: Abeysinghe, Gayan
Published: (2023)

The ALERT Score: A Clinical Tool to Enrich for Trial‐Eligible Liver Fat Content in MASH and MASLD Clinical Trials
by: Magdalena Nowak, et al.
Published: (2025)

Eligibility-Aware Evidence Synthesis: An Agentic Framework for Clinical Trial Meta-Analysis
by: Zhao, Yao, et al.
Published: (2026)

Rapid Progressors in Alzheimer's Disease: Implications for Symptomatic Clinical Trial Design
by: Madison Shyer, et al.
Published: (2025)

SiteRx AI‐Enabled Clinical Intelligence Platform Delivers Superior Amyloid PET Conversion in Early Alzheimer’s Disease (AD) Trial
by: Erin Beck, et al.
Published: (2024)

Prompting Large Language Models for Clinical Temporal Relation Extraction
by: He, Jianping, et al.
Published: (2024)

Neuroimaging in Atypical AD: Considerations for Clinical Trials
by: Jennifer L. Whitwell
Published: (2025)

Drain Site Herniation of the Vermiform Appendix: A Rare Complication Following Laparotomy
by: Abeysinghe AHMGB1*, Jayasooriya HK2, Abeysinghe AHMCD3
Published: (2026)

AD-GPT: Large Language Models in Alzheimer's Disease
by: Liu, Ziyu, et al.
Published: (2025)

Feasibility of Identifying Aerobic‐Fitness Responses to Aerobic Exercise in Alzheimer's Disease: The FIT‐AD SMART Trial
by: Fang Yu, et al.
Published: (2025)

Reply to Williams et al.: Fair and Safe Eligibility Criteria for Women's Sport
by: Ross Tucker, et al.
Published: (2024)

Sex Differences in Disc Golf Performance: Implications for Eligibility Criteria for Women's Competitions
by: Tommy R. Lundberg, et al.
Published: (2025)

Clinical Trials Ontology Engineering with Large Language Models
by: Çakır, Berkan
Published: (2024)

Estimating Potential Eligibility for Disease Modifying Therapies for Alzheimer’s Disease Using Population‐Based Data in Alberta, Canada
by: Mohammad Z I Chowdhury, et al.
Published: (2024)

Warmth of the welcome: Immigration and local housing price dynamics
by: Xun Bian, et al.
Published: (2025)

A Real‐World Data‐Based Analysis of Prognostic Indices as Part of Trial Eligibility Criteria in Diffuse Large B‐Cell Lymphoma Patients
by: Jelena Jelicic, et al.
Published: (2024)

An Ontology for Representing Curriculum and Learning Material
by: Christou, Antrea, et al.
Published: (2025)

Lower Risk of Alzheimer’s Disease and Related Dementias associated with Angiotensin Receptor II Blockers (ARBs) treatment for individuals with Hypertension in High‐volume Claims Data
by: Sori Kim Lundin, et al.
Published: (2024)

Antiviral therapy: Valacyclovir Treatment of Alzheimer's Disease (VALAD) Clinical Trial
by: Davangere P. Devanand, et al.
Published: (2025)

Identifying Problematic Subjects Entering Clinical Trials in Early Alzheimer’s Disease
by: Alan Kott, et al.
Published: (2025)

Impacts of Informant Replacement in Industry‐Sponsored Alzheimer’s Disease Clinical Trials
by: Mikaela K Nishida, et al.
Published: (2024)

Optimizing Alzheimer’s Disease Clinical Trials with Predictive Models of Cognitive Decline
by: Bhargav Teja Nallapu, et al.
Published: (2025)

Robust Causal Inference for EHR-based Studies of Point Exposures with Missingness in Eligibility Criteria
by: Benz, Luke, et al.
Published: (2025)

The Challenges of Evaluating LLM Applications: An Analysis of Automated, Human, and LLM-Based Approaches
by: Abeysinghe, Bhashithe, et al.
Published: (2024)

Dose Individualization for Phase I Cancer Trials With Broadened Eligibility
by: Rebecca B. Silva, et al.
Published: (2024)

On the Calibration of Bayesian Success Criteria and Operating Characteristics for Clinical Trials
by: Yang, Peng, et al.
Published: (2026)